PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway.
about
PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
PARK14 PLA2G6 mutants are defe ...... tochondrial apoptotic pathway.
@en
PARK14 PLA2G6 mutants are defe ...... tochondrial apoptotic pathway.
@nl
type
label
PARK14 PLA2G6 mutants are defe ...... tochondrial apoptotic pathway.
@en
PARK14 PLA2G6 mutants are defe ...... tochondrial apoptotic pathway.
@nl
prefLabel
PARK14 PLA2G6 mutants are defe ...... tochondrial apoptotic pathway.
@en
PARK14 PLA2G6 mutants are defe ...... tochondrial apoptotic pathway.
@nl
P2093
P2860
P356
P1433
P1476
PARK14 PLA2G6 mutants are defe ...... itochondrial apoptotic pathway
@en
P2093
Chao-Lang Chen
Chin-Song Lu
Hsin-Yi Chen
Hung-Li Wang
Szu-Chia Lai
Tu-Hsueh Yeh
Yan-Wei Lin
Yi-Chuan Cheng
Yi-Hsin Weng
Yin-Cheng Huang
P2860
P304
79046-79060
P356
10.18632/ONCOTARGET.20893
P407
P577
2017-09-15T00:00:00Z